Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing off
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing off ; volume:14 ; number:1 ; day:26 ; month:7 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (26.7.2024), 1-10, 12.2024
- Urheber
-
Leodori, Giorgio
Mancuso, Marco
Maccarrone, Davide
Tartaglia, Matteo
Ianniello, Antonio
Certo, Francesco
Ferrazzano, Gina
Malimpensa, Leonardo
Belvisi, Daniele
Pozzilli, Carlo
Berardelli, Alfredo
Conte, Antonella
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-68322-w
- URN
-
urn:nbn:de:101:1-2410250841087.533795752768
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Leodori, Giorgio
- Mancuso, Marco
- Maccarrone, Davide
- Tartaglia, Matteo
- Ianniello, Antonio
- Certo, Francesco
- Ferrazzano, Gina
- Malimpensa, Leonardo
- Belvisi, Daniele
- Pozzilli, Carlo
- Berardelli, Alfredo
- Conte, Antonella
- SpringerLink (Online service)
Ähnliche Objekte (12)
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Fatigue Management in Multiple Sclerosis
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Insight into metabolic 1H-MRS changes in natalizumab induced progressive multifocal leukoencephalopathy brain lesions
Gillian Wearing
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Fatigue Management in Multiple Sclerosis
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Insight into metabolic 1H-MRS changes in natalizumab induced progressive multifocal leukoencephalopathy brain lesions
Gillian Wearing
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod
Natalizumab in Early Relapsing-Remitting Multiple Sclerosis: A 4-Year, Open-Label Study
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Fatigue Management in Multiple Sclerosis
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Insight into metabolic 1H-MRS changes in natalizumab induced progressive multifocal leukoencephalopathy brain lesions
Gillian Wearing
Extended interval dosing strategies in multiple sclerosis: insights from natalizumab and ocrelizumab trials
GP6 rs2304166 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimod